金安國紀(002636.SZ):擬以全資子公司名義在上海松江區九亭購買商業房產
格隆匯5月6日丨金安國紀(002636.SZ)公佈,2020年4月30日,公司第四屆董事會第十九次會議通過了《關於子公司擬購置房產的議案》,同意公司擬以全資子公司上海國紀電子材料有限公司名義購買位於上海市松江區滬亭北路199弄7幢1號5層的商業房產作為公司醫藥事業部辦公場所使用,該房屋實測建築面積為1423.54平方米,房屋總價不超過4500萬元人民幣。此次購買房產的合同簽訂、款項支付等具體事宜由董事會授權公司管理層全權辦理。
此次在上海松江區九亭購買的商業房產,鄰近市區,便於商務人才聚集,作為醫藥事業部的辦公場所,有利於人才的吸納、業務的開展以及生活通勤的便利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.